Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06307340 · ClinicalTrials.gov registry record · NA
Adaption of the STAIR-NT Trauma Intervention for Polysubstance Populations
A NA study of Post Traumatic Stress Disorder and Polysubstance Abuse, sponsored by NYU Langone Health.
- Active
- Registry status
- NA
- Development phase
- 76
- Enrollment target
- 3
- Study locations
NCT06307340: Active NA study of Post Traumatic Stress Disorder and Polysubstance Abuse, sponsored by NYU Langone Health.
NCT06307340 is a NA study of Post Traumatic Stress Disorder and Polysubstance Abuse that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 76 participants, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (89% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06307340, a NA study of Post Traumatic Stress Disorder and Polysubstance Abuse, is active but no longer recruiting, sponsored by NYU Langone Health.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 76 participants
- Enrollment target
- 3
- Study locations
Study Summary
During this 36-month R34 trial, eight study phases are proposed to adapt an evidence-based post traumatic stress disorder (PTSD) intervention (STAIR-NT) and layer it into a methadone maintenance treatment (MMT) program (START Treatment and Recovery centers) in New York City for use among individuals engaged in stimulant-opioid polysubstance use. The study aims to adapt STAIR-NT to a massed treatment schedule. Once an adapted protocol is complete, it will be tested for feasibility, acceptability, and short-term polysubstance and PTSD symptomology outcomes in a pilot randomized control trial (RCT) of 80 participants. Participants who screen eligible and consent will be randomized 1:1 to the adapted STAIR-NT intervention or treatment as usual (TAU) using randomization blocks of two and two and four via a computer-generated randomization sequence. Participants assigned to the intervention will receive the adapted massed delivery of STAIR-NT by trained counselors.
Primary Outcome
Proportion of persons eligible to enroll in the study of all possible MMT patients approached. Assessed using count data of individuals failing screen.
Conditions Studied
Interventions
- BEHAVIORAL Treatment as Usual
- BEHAVIORAL Skills Training in Affective and Interpersonal Regulation with Narrative Therapy (STAIR-NT)
Study Locations (3)
New York
- START Treatment and Recovery Centers - Brooklyn
- NYU Langone Health - New York
Florida
- Florida State University - Tallahassee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2024-10-14 |
| Est. Completion | 2026-09-30 |
| Phase | NA |
What the registry record for NCT06307340 still lists
NCT06307340 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 664-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target (89% lower).
The record links to 2 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual is the first listed.
NCT06307340 reports a single indexed study location in New York, Florida.
Frequently Asked Questions
What is clinical trial NCT06307340 about?
NCT06307340 is a clinical study titled "Adaption of the STAIR-NT Trauma Intervention for Polysubstance Populations". During this 36-month R34 trial, eight study phases are proposed to adapt an evidence-based post traumatic stress disorder (PTSD) intervention (STAIR-NT) and layer it into a methadone maintenance treatment (MMT) program (START Treatment and Recovery centers) in New York City for use among individuals...
What is the current status of trial NCT06307340?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 76 participants. The study started on 2024-10-14. Estimated completion is 2026-09-30.
What conditions does trial NCT06307340 study?
This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Polysubstance Abuse.
What interventions are being tested in trial NCT06307340?
The interventions under investigation include: Treatment as Usual (BEHAVIORAL), Skills Training in Affective and Interpersonal Regulation with Narrative Therapy (STAIR-NT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06307340?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06307340 being conducted?
This trial has 3 study locations across Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Post Traumatic Stress Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06307340's enrollment target sits among peer trials
76 143rd of 262 higher than 118 of 262 other Post Traumatic Stress Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
CRISOL Mente: A Multilevel Community Intervention to Reduce Mental Health Disparities Among Latinos
RECRUITING · NA
-
TMS-fNIRS Personalized Dosing
RECRUITING · NA
-
Targeting the Default Mode Network: A TMS-fMRI Study
RECRUITING · NA
-
The Effects of Very Brief Exposure on PTSD in U.S. Combat Veterans
RECRUITING · NA
-
Fear and Avoidance in PTSD Patients
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02615184 · 76 participants · Phase 2
A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old
- NCT02821741 · 76 participants · NA
Effects of External Ear Stimulation on Pain Perception and Mood
- NCT03019757 · 76 participants
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
- NCT03353584 · 76 participants · NA
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI